Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration

20234 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov identifier, NCT01527435.

Published in: Ophthalmology and Therapy

Volume 12, Issue 5, pp. 2583-2608

Field-Weighted Citation Impact: 1.13